• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS205
Device Problems Break (1069); Biocompatibility (2886); Material Integrity Problem (2978); Insufficient Information (3190); Patient Device Interaction Problem (4001)
Patient Problems Uterine Perforation (2121); Foreign Body In Patient (2687); Device Embedded In Tissue or Plaque (3165)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of embedded device ('embedded in her tissues') and device breakage ('due to the device remains that the (b)(6) employees left in the body of my client during the surgical procedure, she still suffers various ailments') in a (b)(6) female patient who had essure (ess205) inserted.The occurrence of additional non-serious events is detailed below.Medical conditions: no relevant past medical history.On (b)(6) 2004, the patient had essure (ess205) inserted.On an unknown date, the patient experienced embedded device (seriousness criteria medically significant and intervention required), device breakage (seriousness criterion medically significant), complication of device removal ("due to the device remains that the (b)(6) employees left in the body of my client during the surgical procedure, she still suffers various ailments"), pelvic pain ("pelvic pain"), swelling ("swelling"), hypersensitivity ("allergic reactions"), back pain ("lumbar pain for more than 10 years"), abdominal pain ("abdominal pain"), vulvovaginal pain ("vaginal pain"), abdominal pain lower ("cramps"), alopecia ("loss of hair"), allergy to metals ("allergic to nickel and titanium sulphate"), inflammation ("abdominal inflammation"), coccydynia ("moderate coccyx pain"), endometriosis ("focal endometriosis"), muscle disorder ("muscle hyperplasia"), diarrhoea ("chronic diarrhoea"), arthralgia ("joint pain"), myalgia ("muscle pain"), tremor ("heavy hand tremors"), spinal osteoarthritis ("lumbar spondylosis with pinching of spaces l4-l5 and l5-s1") and facet joint syndrome ("facet syndrome").The patient was treated with surgery (bilateral radical salpingectomy in (b)(6) 2019).At the time of the report, the embedded device, device breakage, complication of device removal, pelvic pain, swelling, hypersensitivity, abdominal pain, vulvovaginal pain, abdominal pain lower, alopecia, allergy to metals, diarrhoea, arthralgia, myalgia and tremor outcome was unknown and the back pain, inflammation, coccydynia, endometriosis, muscle disorder, spinal osteoarthritis and facet joint syndrome had not resolved.The reporter considered abdominal pain, abdominal pain lower, allergy to metals, alopecia, arthralgia, back pain, coccydynia, complication of device removal, device breakage, diarrhoea, embedded device, endometriosis, facet joint syndrome, hypersensitivity, inflammation, muscle disorder, myalgia, pelvic pain, spinal osteoarthritis, swelling, tremor and vulvovaginal pain to be related to essure (ess205).Diagnostic results (normal ranges are provided in parenthesis if available): allergy test - on an unknown date: allergic to nickel and titanium sulphate.Computerised tomogram on an unknown date: allergy to nickel in left fallopian tube essure, very superficial.X-ray on (b)(6) 2019: no metallic remains.Based on the available information, a review of our complaint records and other relevant data will be conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Manufacturer Narrative
This spontaneous case was reported by a lawyer and describes the occurrence of embedded device ('embedded in her tissues') and device breakage ('due to the device remains that the sas employees left in the body of my client during the surgical procedure, she still suffers various ailments') in a 40-year-old female patient who had essure (ess205) inserted.The occurrence of additional non-serious events is detailed below.Medical conditions: no relevant past medical history.On (b)(6) 2004, the patient had essure (ess205) inserted.On an unknown date, the patient experienced embedded device (seriousness criteria medically significant and intervention required), device breakage (seriousness criterion medically significant), complication of device removal ("due to the device remains that the sas employees left in the body of my client during the surgical procedure, she still suffers various ailments"), pelvic pain ("pelvic pain"), swelling ("swelling"), hypersensitivity ("allergic reactions"), back pain ("lumbar pain for more than 10 years"), abdominal pain ("abdominal pain"), vulvovaginal pain ("vaginal pain"), abdominal pain lower ("cramps"), alopecia ("loss of hair"), allergy to metals ("allergic to nickel and titanium sulphate"), inflammation ("abdominal inflammation"), coccydynia ("moderate coccyx pain"), endometriosis ("focal endometriosis"), muscle hypertrophy ("muscle hyperplasia"), diarrhoea ("chronic diarrhoea"), arthralgia ("joint pain"), myalgia ("muscle pain"), tremor ("heavy hand tremors"), spinal osteoarthritis ("lumbar spondylosis with pinching of spaces l4-l5 and l5-s1") and facet joint syndrome ("facet syndrome").The patient was treated with surgery (bilateral radical salpingectomy in (b)(6) 2019).At the time of the report, the embedded device, device breakage, complication of device removal, pelvic pain, swelling, hypersensitivity, abdominal pain, vulvovaginal pain, abdominal pain lower, alopecia, allergy to metals, diarrhoea, arthralgia, myalgia and tremor outcome was unknown and the back pain, inflammation, coccydynia, endometriosis, muscle hypertrophy, spinal osteoarthritis and facet joint syndrome had not resolved.The reporter considered abdominal pain, abdominal pain lower, allergy to metals, alopecia, arthralgia, back pain, coccydynia, complication of device removal, device breakage, diarrhoea, embedded device, endometriosis, facet joint syndrome, hypersensitivity, inflammation, muscle hypertrophy, myalgia, pelvic pain, spinal osteoarthritis, swelling, tremor and vulvovaginal pain to be related to essure (ess205).Diagnostic results (normal ranges are provided in parenthesis if available): allergy test - on an unknown date: allergic to nickel and titanium sulphate.Computerised tomogram - on an unknown date: allergy to nickel in left fallopian tube essure, very superficial.X-ray - on (b)(6) 2019: no metallic remains.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 25-may-2020: quality safety evaluation of ptc.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Manufacturer Narrative
This spontaneous case was originally reported by a lawyer on behalf of a consumer and describes the occurrence of embedded device ("embedded in her tissues") and device breakage ("due to the device remains that the sas employees left in the body of my client during the surgical procedure, she still suffers various ailments") in a 40 year-old female patient who had essure (ess205) inserted.Additional non-serious events are detailed below.Product or product use issues identified: contraceptive device removal incomplete ("due to the device remains that the sas employees left in the body of my client during the surgical procedure, she still suffers various ailments").The patient had a medical history of sacral pain and lumbar pain in 2011 and parity 2, gravida ii, paraesthesia of limbs and cervicobrachialgia.No relevant past medical history.Previously administered products included: oral contraceptive nos, nsaid n and benzodiazepine derivatives.On (b)(6) 2004, the patient had essure (ess205) inserted.Essure (ess205) was removed on (b)(6) 2019.An unknown time later she experienced embedded device (seriousness criteria medically important and intervention required), device breakage (seriousness criterion medically important), pelvic pain ("pelvic pain"), swelling ("swelling"), hypersensitivity ("allergic reactions"), back pain ("lumbar pain for more than 10 years"), abdominal pain ("abdominal pain"), vulvovaginal pain ("vaginal pain"), abdominal pain lower ("cramps"), alopecia ("loss of hair"), allergy to metals ("allergic to nickel and titanium sulphate"), inflammation ("abdominal inflammation"), coccydynia ("moderate coccyx pain"), endometriosis ("focal endometriosis"), muscle hypertrophy ("muscle hyperplasia"), diarrhoea ("chronic diarrhoea"), arthralgia ("joint pain"), myalgia ("muscle pain"), tremor ("heavy hand tremors"), spinal osteoarthritis ("lumbar spondylosis with pinching of spaces l4-l5 and l5-s1") and facet joint syndrome ("facet syndrome").The patient was treated with surgery (bilateral radical salpingectomy in (b)(6) 2019).At the time of the report, the back pain, inflammation, coccydynia, endometriosis, muscle hypertrophy, spinal osteoarthritis and facet joint syndrome had not resolved.The outcomes for embedded device, device breakage, pelvic pain, swelling, hypersensitivity, abdominal pain, vulvovaginal pain, abdominal pain lower, alopecia, allergy to metals, diarrhoea, arthralgia, myalgia and tremor were unknown.The reporter considered abdominal pain, abdominal pain lower, allergy to metals, alopecia, arthralgia, back pain, coccydynia, device breakage, diarrhoea, embedded device, endometriosis, facet joint syndrome, hypersensitivity, inflammation, muscle hypertrophy, myalgia, pelvic pain, spinal osteoarthritis, swelling, tremor and vulvovaginal pain to be related to essure (ess205) administration.The reporter commented: coil rings in right tube: 3; coil rings in left tube: 8.In addition, due to the remains of the devices that the healthcare professionals at sas left inside her body, she still experiences ailments to this day: abdominal inflammation, low back pain, moderate tailbone pain, focal endometriosis and muscle hyperplasia.Diagnostic results (normal ranges are provided in parenthesis if available): [allergy test] (date unknown): allergic to nickel and titanium sulphate [computerised tomogram] (date unknown): allergy to nickel in left fallopian tube essure, very superficial.[x-ray] on (b)(6) 2004: it was confirmed that the insertion had been achieved successfully.The patient did not require treatment after the insertion of the device and her menstrual pattern had not changed.The patient¿s own assessment of the method was that it was very satisfactory.; on (b)(6) 2019: no metallic remains.Quality-safety evaluation of ptc: for essure (ess205): unable to confirm complaint.The most recent follow-up information incorporated above includes data received on: 03-jan-2023: patient date of birth, medical history, lab data, product removal date, reporter causality comment added.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, nj, NJ 07981
MDR Report Key10066864
MDR Text Key196773428
Report Number2951250-2020-07834
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeES
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 01/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS205
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age40 YR
Patient SexFemale
-
-